| http://www.w3.org/ns/prov#value | - -155 may serve as biomarkers of liver injury and inflammation, respectively.1The concept that miRNAs in serum and plasma are powerful potential biomarkers for liver diseases has expanded very quickly in recent years, and the role of circulating miR-122 in predicting liver damage has been replicated in liver diseases of different etiologies, including human nonalcoholic fatty liver disease (NAFLD).
|
